Clin2
NCT07146945Likely a fitNot yet recruiting

Safety study of single doses of S1-221 in healthy volunteers

Healthy Participants

Treatments studied

This study tests the safety and how the body reacts to single doses of a new drug called S1-221. It is for healthy volunteers to help researchers understand potential side effects before testing in patients.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
84 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are between 18 and 65 years old.
  • You are in good general health with no serious medical conditions.
  • Your body mass index (BMI) is between 18 and 32, and you weigh at least 50 kg.
  • You do not smoke heavily and can avoid tobacco/nicotine during the study.
  • You are willing to use effective birth control during and for a period after the study.
  • You can avoid alcohol, certain foods (like grapefruit and coffee), and other medications as instructed.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07771777Not yet recruiting· Phase 1
Safety study of an experimental drug in healthy adults

This trial tests a new investigational drug called SYH2056 in healthy volunteers to see if it is safe and how the body handles it. It also checks how food affects the drug. Participating may help determine if the drug can be developed for future patients.

NCT07463196Recruiting· Phase 1
Safety study of ACI-19764 in healthy adults

This trial tests a new oral medication, ACI-19764, in healthy adults to see how safe it is and how the body processes it. It may help researchers understand how the drug affects the immune system, which could lead to future treatments for certain conditions.

Groningen
NCT07412353Recruiting· Phase 1
Testing safety of single dose SYH2085 in healthy people

This study tests a single dose of an investigational drug called SYH2085 in healthy volunteers to check for side effects, how the body processes the drug, and what happens at different doses. If you qualify, you will help doctors understand if the drug is safe before testing it in patients.

Shanghai, Shanghai Municipality
NCT07510958Not yet recruiting· Phase 1
Testing an Inhaled Drug for Safety in Healthy Adults

This study tests an inhaled medication called SYH2059 to see how safe it is and how the body processes it. It is for healthy adults and involves taking the drug once or multiple times to measure its effects.

NCT06877611Recruiting· Phase 1
Testing the drug S-4321 in healthy volunteers for safety

This trial tests a new drug called S-4321 to make sure it's safe and well-tolerated in healthy people. You would take the drug and have regular check-ups to see how your body handles it.

Bayswater, Victoria
NCT07580794Recruiting· Phase 1
Safety Study of New Drug HSK56630 in Healthy People

This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.

Bayswater, Victoria

Hear when a new Healthy Participants trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.